» Articles » PMID: 18712538

Photodynamic Inactivation of Recombinant Bioluminescent Escherichia Coli by Cationic Porphyrins Under Artificial and Solar Irradiation

Overview
Specialty Biotechnology
Date 2008 Aug 21
PMID 18712538
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

A faster and simpler method to monitor the photoinactivation process of Escherichia coli involving the use of recombinant bioluminescent bacteria is described here. Escherichia coli cells were transformed with luxCDABE genes from the marine bioluminescent bacterium Vibrio fischeri and the recombinant bioluminescent indicator strain was used to assess, in real time, the effect of three cationic meso-substituted porphyrin derivatives on their metabolic activity, under artificial (40 W m(-2)) and solar irradiation (approximately 620 W m(-2)). The photoinactivation of bioluminescent E. coli is effective (>4 log bioluminescence decrease) with the three porphyrins used, the tricationic porphyrin Tri-Py+-Me-PF being the most efficient compound. The photoinactivation process is efficient both with solar and artificial light, for the three porphyrins tested. The results show that bioluminescence analysis is an efficient and sensitive approach being, in addition, more affordable, faster, cheaper and much less laborious than conventional methods. This approach can be used as a screening method for bacterial photoinactivation studies in vitro and also for the monitoring of the efficiency of novel photosensitizer molecules. As far as we know, this is the first study involving the use of bioluminescent bacteria to monitor the antibacterial activity of porphyrins under environmental conditions.

Citing Articles

Can Porphyrin-Triphenylphosphonium Conjugates Enhance the Photosensitizer Performance Toward Bacterial Strains?.

Chaves I, Morais F, Vieira C, Bartolomeu M, Faustino M, Neves M ACS Appl Bio Mater. 2024; 7(8):5541-5552.

PMID: 39008849 PMC: 11337165. DOI: 10.1021/acsabm.4c00659.


Application of the Resazurin Cell Viability Assay to Monitor and Typhimurium Inactivation Mediated by Phages.

Costa P, Gomes A, Braz M, Pereira C, Almeida A Antibiotics (Basel). 2021; 10(8).

PMID: 34439024 PMC: 8389016. DOI: 10.3390/antibiotics10080974.


Bacteriophages with Potential to Inactivate in Cockles: In Vitro and In Vivo Preliminary Studies.

Duarte J, Pereira C, Costa P, Almeida A Antibiotics (Basel). 2021; 10(6).

PMID: 34204770 PMC: 8231581. DOI: 10.3390/antibiotics10060710.


Photodynamic inactivation of : lighting the way towards an environmentally friendly phytosanitary treatment.

Garcia M, David B, Sierra-Garcia I, Faustino M, Alves A, Esteves A Biol Lett. 2021; 17(4):20200820.

PMID: 33878276 PMC: 8086943. DOI: 10.1098/rsbl.2020.0820.


Cationic Pyrrolidine/Pyrroline-Substituted Porphyrins as Efficient Photosensitizers against .

Ladeira B, Dias C, Gomes A, Tome A, Neves M, Moura N Molecules. 2021; 26(2).

PMID: 33477299 PMC: 7829939. DOI: 10.3390/molecules26020464.


References
1.
Ashkenazi H, Nitzan Y, Gal D . Photodynamic effects of antioxidant substituted porphyrin photosensitizers on gram-positive and -negative bacterial. Photochem Photobiol. 2003; 77(2):186-91. DOI: 10.1562/0031-8655(2003)077<0186:peoasp>2.0.co;2. View

2.
Maisch T, Szeimies R, Jori G, Abels C . Antibacterial photodynamic therapy in dermatology. Photochem Photobiol Sci. 2004; 3(10):907-17. DOI: 10.1039/b407622b. View

3.
Burlage R, Sayler G, Larimer F . Monitoring of naphthalene catabolism by bioluminescence with nah-lux transcriptional fusions. J Bacteriol. 1990; 172(9):4749-57. PMC: 213127. DOI: 10.1128/jb.172.9.4749-4757.1990. View

4.
Contag C, Jenkins D, Contag P, Negrin R . Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia. 2000; 2(1-2):41-52. PMC: 1550286. DOI: 10.1038/sj.neo.7900079. View

5.
Francis K, Joh D, Hawkinson M, Purchio T, Contag P . Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun. 2000; 68(6):3594-600. PMC: 97648. DOI: 10.1128/IAI.68.6.3594-3600.2000. View